Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nammi Therapeutics Inc
National Cancer Institute (NCI)
IDEAYA Biosciences
Conjupro Biotherapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
SystImmune Inc.
Pfizer
Mayo Clinic
Xencor, Inc.
ViroMissile, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Baylor College of Medicine
Phrontline Biopharma
Novartis
Degron Therapeutics Co.
University Health Network, Toronto
AstraZeneca
Chongqing Precision Biotech Co., Ltd
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Incyte Corporation
Novita Pharmaceuticals, Inc.
Trishula Therapeutics, Inc.
M.D. Anderson Cancer Center
Monopar Therapeutics
Monopar Therapeutics
Thomas Jefferson University
Columbia University
University of California, Davis
Black Diamond Therapeutics, Inc.
Revolution Medicines, Inc.
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
Inhibrx Biosciences, Inc
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Celldex Therapeutics
University of California, San Francisco
STCube, Inc.
AO GENERIUM
Corvus Pharmaceuticals, Inc.
Lebanese University
Fate Therapeutics
Canadian Cancer Trials Group
Cantargia AB
Viralytics
Bristol-Myers Squibb